Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 3 |
Invesco MSCI USA ETF
PBUS
|
+$1.52B |
| 4 |
Synopsys
SNPS
|
+$1.47B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 2 |
Tesla
TSLA
|
+$2.46B |
| 3 |
Aon
AON
|
+$1.21B |
| 4 |
Oracle
ORCL
|
+$1.04B |
| 5 |
Apple
AAPL
|
+$925M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.08% |
| 2 | Financials | 11.07% |
| 3 | Consumer Discretionary | 8.45% |
| 4 | Communication Services | 7.49% |
| 5 | Healthcare | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Vanguard Russell 2000 Value ETF
VTWV
$1.29B
| $26.8M | ﹤0.01% |
171,670
+21,347
| +14% | +$3.18M |
|
2602
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $26.7M | ﹤0.01% |
1,240,326
+28,011
| +2% | +$588K |
|
2603
Travere Therapeutics
TVTX
$5.29B
| $26.7M | ﹤0.01% |
1,117,037
-451,507
| -29% | -$8.49M |
|
2604
Bloomin' Brands
BLMN
$731M
| $26.7M | ﹤0.01% |
3,722,275
+789,686
| +27% | +$6.35M |
|
|
MRX
2605
Marex Group Limited Ordinary Shares
MRX
$4.66B
| $26.7M | ﹤0.01% |
792,710
-485,145
| -38% | -$17.5M |
|
2606
iRhythm Holdings
IRTC
$3.71B
| $26.6M | ﹤0.01% |
154,871
-23,027
| -13% | -$3.66M |
|
2607
Build-A-Bear
BBW
$428M
| $26.6M | ﹤0.01% |
408,179
+203,290
| +99% | +$12M |
|
2608
iShares International Equity Factor ETF
INTF
$3.57B
| $26.6M | ﹤0.01% |
739,806
+84,192
| +13% | +$2.95M |
|
2609
Amylyx Pharmaceuticals
AMLX
$2.05B
| $26.5M | ﹤0.01% |
1,950,301
+1,463,408
| +301% | +$13.8M |
|
2610
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
| $26.4M | ﹤0.01% |
2,489,840
-192,386
| -7% | -$1.96M |
|
2611
Virtus Terranova US Quality Momentum ETF
JOET
$240M
| $26.3M | ﹤0.01% |
612,217
+229,669
| +60% | +$9.56M |
|
2612
BancFirst
BANF
$3.91B
| $26.3M | ﹤0.01% |
208,226
-10,701
| -5% | -$1.38M |
|
|
DPG
2613
Duff & Phelps Utility and Infrastructure Fund
DPG
$540M
| $26.3M | ﹤0.01% |
2,034,810
+26,991
| +1% | +$339K |
|
2614
Neuropace
NPCE
$524M
| $26.3M | ﹤0.01% |
2,546,208
-38,865
| -2% | -$366K |
|
2615
iShares New York Muni Bond ETF
NYF
$1.38B
| $26.2M | ﹤0.01% |
491,861
+36,323
| +8% | +$1.9M |
|
2616
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
| $26.2M | ﹤0.01% |
547,267
+51,132
| +10% | +$2.29M |
|
2617
Renasant Corp
RNST
$4.02B
| $26.2M | ﹤0.01% |
710,984
+114,991
| +19% | +$4.35M |
|
2618
Remitly
RELY
$4.84B
| $26.2M | ﹤0.01% |
1,608,616
+105,173
| +7% | +$1.89M |
|
2619
Xeris Biopharma Holdings
XERS
$1.44B
| $26.2M | ﹤0.01% |
3,219,701
-422,883
| -12% | -$2.81M |
|
2620
Rogers Corp
ROG
$2.26B
| $26.2M | ﹤0.01% |
325,600
+726
| +0.2% | +$54.1K |
|
2621
Patterson-UTI
PTEN
$3.58B
| $26.2M | ﹤0.01% |
5,054,129
-2,213,568
| -30% | -$12.7M |
|
2622
Progyny
PGNY
$2.49B
| $26.2M | ﹤0.01% |
1,216,374
-69,430
| -5% | -$1.58M |
|
2623
Myriad Genetics
MYGN
$523M
| $26.2M | ﹤0.01% |
3,616,925
-937,155
| -21% | -$5.56M |
|
2624
Hawaiian Electric Industries
HE
$2.29B
| $26.1M | ﹤0.01% |
2,367,297
+654,820
| +38% | +$7.46M |
|
2625
State Street Multi-Asset Real Return ETF
RLY
$1.26B
| $26.1M | ﹤0.01% |
845,576
+46,867
| +6% | +$1.41M |
|
Similar funds
Morgan Stanley's Q3 2025 Portfolio in Review
As of Q3 2025, Morgan Stanley held 8,451 positions worth $1.65T, up 7.6% from $1.54T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q3 2025 filing shows 366 new, 3,476 increased, 3,386 reduced and 291 closed positions. Its largest new stake was Paramount Skydance Corp: 14,829,379 shares worth $281M. The largest sale was Alphabet (Google) Class A, an estimated $2.63B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q3 2025 buy was Paramount Skydance Corp: 14,829,379 shares worth $281M.
- Morgan Stanley added most to Invesco QQQ Trust in Q3 2025, an estimated $2.4B increase.
- Morgan Stanley's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $2.63B.
- Morgan Stanley fully exited Paramount Global Class B in Q3 2025, selling an estimated $521M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.65T portfolio in Q3 2025.
- Morgan Stanley opened 366 new positions and closed 291 in Q3 2025.
- Morgan Stanley's portfolio value rose 7.6% quarter-over-quarter to $1.65T.
Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.